Respiratory continuity
A current clinician-guided service provides structured support between appointments.
DPIIT-recognised deep-tech startup
Hard questions deservedisciplined technology.
VSNOVA develops biological measurement technology for longitudinal health research, focused on questions where biology, time and clinical meaning cannot be separated. Every application remains bounded by the evidence required for that specific use.
Deep-tech R&DClinically groundedBuilt in India
What makes the work deep tech
The difficulty is scientific, not cosmetic.
Deep technology earns its place by reducing uncertainty in a difficult problem, not by adding complexity to the explanation.
- 01
Biological measurement
The work studies how meaningful biological change can be followed across time in defined health contexts.
- 02
Clinical meaning
A technical question matters only when it is connected to a real person, setting and decision.
- 03
Measured uncertainty
Limitations, sources of variation and unanswered questions remain visible throughout development.
- 04
Independent validation
Every intended use must earn its own evidence before a clinical or commercial claim can expand.
Two timescales
Value in the present. Research for the future.
The commercial programme and the R&D portfolio are connected by a long-term view of health, but they are not the same product and do not share the same claims.
Oncology
Research questions around change during treatment, supportive care, recovery and rehabilitation.
Longitudinal biohealth
New ways to study relevant biological states as they vary between people and over time.
Evidence discipline
A plausible idea is not yet a clinical claim.
Every future use requires a defined purpose, appropriate clinical references, prospective studies, independent validation and the relevant regulatory review. External research may justify a question; it does not validate a VSNOVA product.
Company recognition
Recognised by DPIIT as a Deep Tech Startup.
Certificate DIPP281271 records VSNOVA Biohealth Private Limited as a Deep Tech Startup. It was issued on 4 September 2026.
Recognition recordDIPP281271
This recognition is a company classification. It is not a product approval, clinical validation or regulatory clearance.
See where the research could matter.
Explore the current respiratory service and VSNOVA's carefully bounded application horizons, including oncology.